1.Effect of donor and recipient genotype upon the heart-lung transplantation in mice.
The Journal of the Korean Society for Transplantation 1991;5(1):135-142
No abstract available.
Animals
;
Genotype*
;
Heart-Lung Transplantation*
;
Humans
;
Mice*
;
Tissue Donors*
2.Pancreas Islet Cell Transplantation.
Journal of the Korean Medical Association 2000;43(7):629-633
No abstract available.
Islets of Langerhans*
;
Pancreas*
3.Delirium and Cold Sweating.
Journal of the Korean Medical Association 2000;43(5):475-480
4.A clinical analysis of tetanus.
Journal of the Korean Surgical Society 1991;40(1):77-87
No abstract available.
Tetanus*
5.A case of immune hemolytic anemia due to anti-B induced by group A cadaveric homograft in a group AB renal transplant recipient.
Mee Na KIM ; Dae Won KIM ; Duck Jong HAN
Korean Journal of Blood Transfusion 1991;2(2):205-209
No abstract available.
Allografts*
;
Anemia, Hemolytic*
;
Cadaver*
;
Transplantation*
6.Leiomyosarcoma arising from the inferior vena cava: a case report
Duck Jong HAN ; Suk Koo KIM ; Young Wha JUNG
Journal of the Korean Society for Vascular Surgery 1992;8(1):90-95
No abstract available.
Leiomyosarcoma
;
Vena Cava, Inferior
7.The role of NK cell in heart-lung transplanted mice.
Duck Jong HAN ; Kun Choon PARK ; In Koo KIM ; Dae Won KIM ; Kyung Sook CHUNG
The Journal of the Korean Society for Transplantation 1991;5(1):143-149
No abstract available.
Animals
;
Killer Cells, Natural*
;
Mice*
8.Accelerated Acute Rejection in Renal Allograft: Analysis of prognostic factors.
Journal of the Korean Surgical Society 1997;52(1):148-154
Accelerated acute rejection(AAR) is a rare condition and has a poor prognosis in graft survival following renal transplantation. To elucidate its characteristics, we analysed 14 cases(5.0%) of AAR among 279 renal transplantation. AAR is defined as a condition in which immediate postoperative urine output is good followed by decreased urine output and increase of serum creatinine level within 7 days after transplantation. The incidence of AAR was more prevalent in cadaveric donors than living donors. One year graft survival was inferior in AAR, namely 8 out 14 cases(57%), than that of the patients without AAR(95.1%). Among the factors affecting graft survival in AAR, age and sex of both donor and recipient, donor condition such as living or cadaveric donor, and preoperative HLA matching had no relevance to a graft survival. Time of onset of AAR has no effect on graft survival either. Postoperative donor lymphocytotoxic test showed positive result in one out of 3 patient despite of all negative findings in the preoperative crossmatching test. Histologic finding such as vasculitis on renal biopsy was related to graft survival. Response of treatment was 55% in initial solumedrol pulse therapy and 20% in secondary OKT3 treatment, with an overall effect of 57%. Rerejection developed in 4 out of 8 cases of graft survival group while all cases showed a good function at post operative two years. Graft survival following AAR remains low and AAR is one of the main cause of graft loss following renal transplantation. To illustrate its characteristics, more clinical analysis are required.
Allografts*
;
Biopsy
;
Cadaver
;
Creatinine
;
Graft Survival
;
Humans
;
Incidence
;
Kidney Transplantation
;
Living Donors
;
Methylprednisolone Hemisuccinate
;
Muromonab-CD3
;
Prognosis
;
Tissue Donors
;
Transplants
;
Vasculitis
9.Role of T-lymphocyte in the heart-lung transplanted mouse.
Dae Yune JEONG ; Duck Jong HAN ; Dai Won YOON ; Soo Tong PAI ; Gu KANG ; In Chul LEE
Journal of the Korean Surgical Society 1992;43(4):489-497
No abstract available.
Animals
;
Mice*
;
T-Lymphocytes*